SUPN INDV Supernus Pharmaceuticals and Indivior Pharmaceuticals to merge, creating a diversified Cns biopharmaceutical leader with significa
SUPN INDV Supernus Pharmaceuticals and Indivior Pharmaceuticals to merge, creating a diversified Cns biopharmaceutical leader with significant scale Supernus Pharmaceuticals Inc - combined entity to be named Supernus, Inc. and Jack khattar to serve as President and Chief Executive Officer - Definitive agreement to combine in a tax-free all-stock merger
SUPN INDV Supernus Pharmaceuticals and Indivior Pharmaceuticals to merge, creating a diversified Cns biopharmaceutical leader with significant scale Supernus Pharmaceuticals Inc - combined entity to be named Supernus, Inc. and Jack khattar to serve as President and Chief Executive Officer - Definitive agreement to combine in a tax-free all-stock merger